[Cool]

3
Comment
Favorite

LuffyDono
2021-09-07

[Cool]

Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker

TOKYO, Sept 7 (Reuters) - Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to

Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":817705439,"tweetId":"817705439","gmtCreate":1630985582221,"gmtModify":1676530435017,"author":{"id":3579212601855354,"idStr":"3579212601855354","authorId":3579212601855354,"authorIdStr":"3579212601855354","name":"LuffyDono","avatar":"https://static.tigerbbs.com/e2c4cfc638f53752da999b29aa117d5b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><span>[Cool]&nbsp;</span><br></p></body></html>","htmlText":"<html><head></head><body><p><span>[Cool]&nbsp;</span><br></p></body></html>","text":"[Cool]","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/817705439","repostId":2165649339,"repostType":4,"repost":{"id":"2165649339","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630983223,"share":"https://www.laohu8.com/m/news/2165649339?lang=&edition=full","pubTime":"2021-09-07 10:53","market":"us","language":"en","title":"Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2165649339","media":"Reuters","summary":"TOKYO, Sept 7 (Reuters) - Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to","content":"<p>TOKYO, Sept 7 (Reuters) - Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to purchase 150 million doses of the COVID-19 vaccine it will produce using Novavax Inc's formula.</p>\n<p>Takeda, Japan's biggest drugmaker, is preparing to make the vaccine domestically and will distribute it in early 2022, pending approval from regulators, the company said in a statement. The TAK-019 vaccine is still undergoing clinical trials in Japan, according to Takeda.</p>\n<p>The terms of the deal with the government are confidential, Takeda said.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>The announcement builds on an earlier agreement between Takeda and the government to make some 250 million doses of the Novavax shot. The remaining doses could be given to other countries, Takeda has said previously.</p>\n<p>Japan has donated most of its domestically produced supplies of AstraZeneca Plc's vaccine, relying primarily on imported doses of the mRNA-type shots developed by Pfizer Inc and Moderna Inc for its national inoculation push.</p>\n<p>After a slow start, Japan's vaccination drive has made some progress in recent months, with 58% of the population now having received at least one dose, according to a Reuters tracker.</p>\n<p>Takeda is also handling the import and distribution of some 50 million doses of Moderna's vaccine this year and 50 million more next year. Three batches of Moderna supplies, or about 1.6 million doses, were recalled in Japan after the discovery of small metal contaminants in some vials.</p>\n<p>The health ministry said on Monday that a third person had died after getting a shot from the recalled Moderna supplies. Takeda said in a separate statement on Tuesday that the causes of death https://www.reuters.com/business/healthcare-pharmaceuticals/two-die-japan-after-shots-suspended-moderna-vaccines-japan-govt-2021-08-28 are being investigated, and there is no evidence they are linked to the vaccine.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-07 10:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, Sept 7 (Reuters) - Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to purchase 150 million doses of the COVID-19 vaccine it will produce using Novavax Inc's formula.</p>\n<p>Takeda, Japan's biggest drugmaker, is preparing to make the vaccine domestically and will distribute it in early 2022, pending approval from regulators, the company said in a statement. The TAK-019 vaccine is still undergoing clinical trials in Japan, according to Takeda.</p>\n<p>The terms of the deal with the government are confidential, Takeda said.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>The announcement builds on an earlier agreement between Takeda and the government to make some 250 million doses of the Novavax shot. The remaining doses could be given to other countries, Takeda has said previously.</p>\n<p>Japan has donated most of its domestically produced supplies of AstraZeneca Plc's vaccine, relying primarily on imported doses of the mRNA-type shots developed by Pfizer Inc and Moderna Inc for its national inoculation push.</p>\n<p>After a slow start, Japan's vaccination drive has made some progress in recent months, with 58% of the population now having received at least one dose, according to a Reuters tracker.</p>\n<p>Takeda is also handling the import and distribution of some 50 million doses of Moderna's vaccine this year and 50 million more next year. Three batches of Moderna supplies, or about 1.6 million doses, were recalled in Japan after the discovery of small metal contaminants in some vials.</p>\n<p>The health ministry said on Monday that a third person had died after getting a shot from the recalled Moderna supplies. Takeda said in a separate statement on Tuesday that the causes of death https://www.reuters.com/business/healthcare-pharmaceuticals/two-die-japan-after-shots-suspended-moderna-vaccines-japan-govt-2021-08-28 are being investigated, and there is no evidence they are linked to the vaccine.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165649339","content_text":"TOKYO, Sept 7 (Reuters) - Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to purchase 150 million doses of the COVID-19 vaccine it will produce using Novavax Inc's formula.\nTakeda, Japan's biggest drugmaker, is preparing to make the vaccine domestically and will distribute it in early 2022, pending approval from regulators, the company said in a statement. The TAK-019 vaccine is still undergoing clinical trials in Japan, according to Takeda.\nThe terms of the deal with the government are confidential, Takeda said.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nThe announcement builds on an earlier agreement between Takeda and the government to make some 250 million doses of the Novavax shot. The remaining doses could be given to other countries, Takeda has said previously.\nJapan has donated most of its domestically produced supplies of AstraZeneca Plc's vaccine, relying primarily on imported doses of the mRNA-type shots developed by Pfizer Inc and Moderna Inc for its national inoculation push.\nAfter a slow start, Japan's vaccination drive has made some progress in recent months, with 58% of the population now having received at least one dose, according to a Reuters tracker.\nTakeda is also handling the import and distribution of some 50 million doses of Moderna's vaccine this year and 50 million more next year. Three batches of Moderna supplies, or about 1.6 million doses, were recalled in Japan after the discovery of small metal contaminants in some vials.\nThe health ministry said on Monday that a third person had died after getting a shot from the recalled Moderna supplies. Takeda said in a separate statement on Tuesday that the causes of death https://www.reuters.com/business/healthcare-pharmaceuticals/two-die-japan-after-shots-suspended-moderna-vaccines-japan-govt-2021-08-28 are being investigated, and there is no evidence they are linked to the vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":325,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}